For more than a century, the Department of Pediatrics at Washington University School of Medicine has educated leading physicians and scientists, and is committed to excellence in patient care, basic and clinical research, and teaching. Indeed, the Washington University School of Medicine and St. Louis Children's Hospital are consistently ranked among the best.
The Division of Pediatric Allergy and Pulmonary Medicine at St. Louis Children’s Hospital continues to flourish, supporting premier clinical and research programs in pulmonary and allergic diseases of children. The Division provides exceptional care for children with various allergic and pulmonary diseases, and pursues its academic mission to advance knowledge of the molecular and immunological basis of these conditions and develop novel diagnostic and treatment approaches to improve outcomes of these diseases. Its strong commitment to excellence in patient care, teaching, and investigation was recognized by the Division’s ranking as one of America’s best pulmonary services, according to CHILD magazine’s 2007 survey.
In our Division you will find:
·
active ACGME-accredited pediatric fellowship
training programs in pediatric pulmonology and allergy-immunology,
·
a center that is participating in
three National Institutes of Health-funded childhood asthma
research networks, including the Children’s Asthma Management
Program (CAMP), Childhood Asthma Research and Education Network
(CARE), and the Inner City Asthma Consortium (ICAC),
·
a National Institutes of
Health-sponsored, multidisciplinary center examining pulmonary
complications leading to morbidity and mortality of sickle cell
disease,
·
a cystic fibrosis center that
cares for more than 500 patients and an actively participates in
the Therapeutic Development Network, a Cystic Fibrosis
Foundation-supported program designed to rapidly bring new
therapies to cystic fibrosis patients,
·
a
pediatric lung transplantation program
that cares for the largest cohort of lung and heart-lung
transplant recipients in North America,
·
a center for
the
Genetic Determinants of Mucociliary
Clearance Consortium, part of the National Institutes of Health
Rare Diseases Clinical Research Network, created
to better define pathogenesis and treatment of primary ciliary
dyskinesia and atypical forms of cystic fibrosis,
·
a Sleep Medicine Center and fully
automated Pediatric Sleep Diagnostics Laboratory,
·
a
multispecialty clinic for chronically ill children
who are technology-dependent,
·
a bronchoscopy center where more
than 200 procedures are performed annually,
·
a state-of-the-art pulmonary
function laboratory proficient in performing both pediatric and
infant studies,
routinely serving more than 5000 patient visits each year,
and
·
reknowned research programs that
are examining the cellular and molecular mechanisms and disease
processes of asthma, cystic fibrosis, primary ciliary dyskinesia,
bronchiolitis obliterans, surfactant deficiencies, and
respiratory infections.
or
TOP
SCHOOL OF MEDICINE
